MedPath

Recovery of Patients From COVID-19 After Critical Illness

Completed
Conditions
Critical Illness
COVID-19
Registration Number
NCT04401254
Lead Sponsor
Australian and New Zealand Intensive Care Research Centre
Brief Summary

Patients who are critically ill with COVID-19 requiring life support in an intensive care unit (ICU) have increased risk of morbidity and mortality. Currently the ICU community does not know what effect the disease, the ICU admission, physiotherapy interventions and life support have on their long-term quality of life and whether they can return to their pre-illness level of function following ICU.

COVID-Recovery will describe the physiotherapy interventions delivered to critically ill patients with COVID-19. In survivors, COVID-Recovery will utilise telephone follow-up of ICU survivors to assess disability-free survival and quality of life at 6 months after ICU admission. Additionally, COVID-Recovery will identify if there are predictors of disability-free survival. COVID-Recovery will aim to select up to 300 patients diagnosed with COVID-19 from ICUs in Australia. If they survive to hospital discharge, patients will be invited to receive a telephone questionnaire at 6 months after the ICU admission that aims to assess their long-term outcomes, including physical, cognitive and emotional function, quality of life, and whether they have been able to return to work following ICU discharge.

To describe the experience of critical illness in survivors of COVID-19 and their family members.

To explore and describe functional recovery, respiratory system function and respiratory health morbidity up to 6 months after ICU admission in persistently critically ill adults with COVID-19

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
536
Inclusion Criteria
  1. COVID-19 patients who have been admitted to ICU for > 24 hours
  2. Patients aged over 17 years

Persistent critical illness cohort

  1. As above
  2. An ICU admission of at least 10 consecutive days
Exclusion Criteria
  • Previous enrolment in this study in a prior ICU admission

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Disability-free survival6 months

a composite measure of WHODAS 2.0 - 12 level and hospital survival

Physiotherapy interventionDuring the ICU stay until 3 months

The physiotherapy interventions provided to patients with COVID-19 admitted to the ICU and health outcomes

Secondary Outcome Measures
NameTimeMethod
Cognitive function6 months

Montreal Cognitive Assessment Blind

Screening for post-traumatic distress6 months

Impact of Events Scale Revised

The reported barriers to delivering physiotherapy interventionsDuring the ICU stay until 28 days

Physiotherapist reported barriers to delivering the intervention

Anxiety and depression6 months

Hospital Anxiety and Depression Scale

Adverse events during physiotherapy interventionsDuring the ICU stay until 28 days

Adverse events that require the intervention to be ceased for medical intervention

Health status6 months

Health related quality of life measured with EQ5D-5L score from 0 to 100

Global function6 months

Global Rating of Change

Proportion of patients with COVID-19 who received physiotherapy in ICUDuring the ICU stay until 28 days
Phenomenological data of the patient and family experience6 months

Qualitative interviews

Work Status6 months

WHODAS 2.0

Trial Locations

Locations (29)

Canberra Hospital

🇦🇺

Garran, Australian Capital Territory, Australia

Royal Prince Alfred Hospital

🇦🇺

Camperdown, New South Wales, Australia

Concord Hospital

🇦🇺

Concord, New South Wales, Australia

St Vincent's Hospital Sydney

🇦🇺

Darlinghurst, New South Wales, Australia

Nepean Hospital

🇦🇺

Kingswood, New South Wales, Australia

St George Hospital

🇦🇺

Kogarah, New South Wales, Australia

John Hunter Hospital

🇦🇺

New Lambton Heights, New South Wales, Australia

Royal North Shore Hospital

🇦🇺

Saint Leonards, New South Wales, Australia

Westmead Hospital

🇦🇺

Westmead, New South Wales, Australia

The Prince Charles Hospital

🇦🇺

Chermside, Queensland, Australia

Scroll for more (19 remaining)
Canberra Hospital
🇦🇺Garran, Australian Capital Territory, Australia

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.